Status:
UNKNOWN
Sarcopenia in Older Patient With Prostate Cancer, Prevalence and Incidence After Androgen Deprivation Therapy
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Conditions:
Prostate Cancer
Eligibility:
All Genders
70+ years
Brief Summary
Prostate cancer is the most common cancer among men 50 years and older and mainly affets patients 75 years old. Androgen deprivation therapy is indicatated in intermediates and high risks form of pro...
Eligibility Criteria
Inclusion
- Patients aged 70 years and older
- Proven localized or locally advanced prostate cancer
- Treated by radiotherapy associated to ADT
- CGA needed (screened by G8 Score ≤14)
Exclusion
- Protected pateint under guardiaship
- Metastatic prostate cancer
- Patient refusal
- Patient cripled with severe dementia
Key Trial Info
Start Date :
December 11 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04484246
Start Date
December 11 2019
End Date
December 31 2020
Last Update
July 23 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assistance Publique Hôpitaux de Marseille
Marseille, France, 13354